Detalles de la búsqueda
1.
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece.
Expert Rev Pharmacoecon Outcomes Res
; 22(2): 259-269, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33900864
Resultados
1 -
1
de 1
1
Próxima >
>>